Vitamin D for Immunosuppressed Patients
Immunosuppressed patients — solid-organ transplant recipients, adults on biologics for autoimmune disease, HIV patients, chemotherapy — commonly have low 25(OH)D. Adequate vitamin D supports residual immune function without interfering with intentional immunosuppression, and helps manage bone-density complications of chronic steroid or biologic therapy.
Solid-organ transplant
Kidney, liver, heart, lung, and pancreas transplant recipients require lifelong immunosuppression (typically calcineurin inhibitor + antimetabolite ± steroid). Deficiency rates 60-80% post-transplant. Chronic steroid use + calcineurin inhibitor effects on vitamin D metabolism produce accelerated bone loss. Standard care: cholecalciferol 1,000-2,000 IU/day, calcium 1,000-1,200 mg/day, DEXA monitoring, bisphosphonate for confirmed osteoporosis. Native vitamin D does not interfere with immunosuppression regimens.
Biologic therapy for autoimmune disease
TNF-α inhibitors (adalimumab, infliximab, etanercept), IL-17 inhibitors (secukinumab, ixekizumab), JAK inhibitors, and other biologics create moderate immunosuppression. Vitamin D deficiency is common in the underlying autoimmune diseases and often worsens with reduced sun exposure post-diagnosis. Correction is safe and reasonable general care.
HIV and vitamin D
HIV patients have high deficiency rates. Some antiretrovirals (efavirenz, tenofovir) affect vitamin D metabolism. Standard 1,000-2,000 IU/day is typical; correction of documented deficiency common. Bone-density monitoring is standard given HIV and tenofovir effects on BMD.
Chemotherapy
Vitamin D deficiency is common in cancer patients (illness burden, reduced sun exposure, weight loss). Correction is reasonable adjunctive care. Some chemotherapy agents (glucocorticoids in lymphoma/myeloma regimens) accelerate bone loss requiring vitamin D + calcium and sometimes bisphosphonate. Vitamin D does not interfere with standard chemotherapy efficacy.
Practical monitoring
- Baseline 25(OH)D, calcium, and PTH at immunosuppression start.
- Correct deficiency (2,000-4,000 IU/day for 8-12 weeks).
- Maintenance 1,000-2,000 IU/day.
- Monitor calcium; adjust as needed with immunosuppression regimen changes.
- DEXA at baseline and every 1-2 years on long-term steroids.